Expression of sialic acids in human adult skeletal muscle tissue

Acta Histochemica

Volumn 116, Issue 5, 2014, Pages 926-935

  Marini, Mirca ^a   Ambrosini, Stefano ^a   Sarchielli, Erica ^a   Thyrion, Giorgia Donata Zappoli ^b   Bonaccini, Laura ^a   Vannelli, Gabriella Barbara ^a   Sgambati, Eleonora ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

Aging; Human; Immunohistochemistry; Lectins; Sialic acids; Skeletal muscle

Indexed keywords

LECTIN; MONOCLONAL ANTIBODY; POLYSIALIC ACID; SIALIC ACID DERIVATIVE; N ACETYLNEURAMINIC ACID;

ACETYLATION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUSCLE BIOPSY; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; ADOLESCENT; AGING; ANATOMY AND HISTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALIA;

ADOLESCENT; ADULT; AGED; AGING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; N-ACETYLNEURAMINIC ACID;

EID: 84904060735     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.03.005     Document Type: Article

References (64)

1. Accili D., Menghi G., Gabrielli M.G. Lectin histochemistry for in situ profiling of rat colon sialoglycoconjugates. Histol Histopathol 2008, 23:863-875.
2. Adembri C., Selmi V., Vitali L., Nosi D., Tani A., Zappoli Thyrion G.D., et al. Expression and characterization of anionic components in the tubulointerstitial compartment of rat kidney during polymicrobial sepsis. Acta Histochem 2014, 116:94-105. 10.1016/j.acthis.2013.05.011.
3. Adembri C., Sgambati E., Vitali L., Selmi V., Margheri M., Tani A., et al. Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat. Crit Care 2011, 15:R277.
4. Angata T., Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 2002, 102:439-470.
5. Askanas V., Engel W.K., Nogalska A. Pathogenic considerations in sporadic Inclusion-Body Myositis, a degenerative mus.cle disease associated with aging and abnormalities of myoproteostasis. J Neuropathol Exp Neurol 2012, 71:680-693.
6. Bonaldo P., Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013, 6:25-39.
7. Broccolini A., Gidaro T., De Cristofaro R., Morosetti R., Gliubizzi C., Ricci E., et al. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. J Neurochem 2008, 105:971-981.
8. Broccolini A., Gidaro T., Morosetti R., Mirabella M. Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy. Muscle Nerve 2009, 40:340-349.
9. Broccolini A., Gidaro T., Tasca G., Morosetti R., Rodolico C., Ricci E., et al. Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy. Neurology 2010, 75:265-272.
10. Broccolini A., Gidaro T., Morosetti R., Sancricca C., Mirabella M. Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle. Acta Myol 2011, 30:91-95.
11. Bruni P., Donati C. Pleiotropic effects of sphingolipids in skeletal muscle. Cell Mol Life Sci 2008, 65:3725-3736.
12. Calvani R., Joseph A.M., Adhihetty P.J., Miccheli A., Bossola M., Leeuwenburgh C., et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem 2013, 394:393-414.
13. Clark G.F., Smith P.B. Studies on glycoconjugate metabolism in developing skeletal muscle membranes. Biochim Biophys Acta 1983, 755:56-64.
14. Combs A.C., Ervasti J.M. Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation. Biochem J 2005, 390:303-309.
15. Degens H., Korhonen M.T. Factors contributing to the variability in muscle ageing. Maturitas 2012, 73:197-201.
16. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Med 2004, 34:809-824.
17. Doran P., Donoghue P., O'Connell K., Gannon J., Ohlendieck K. Proteomics of skeletal muscle aging. Proteomics 2009, 9:989-1003.
18. Drey M. Sarcopenia - pathophysiology and clinical relevance. Wien Med Wochenschr 2011, 161:402-408.
19. Drey M., Grösch C., Neuwirth C., Bauer J.M., Sieber C.C. The Motor Unit Number Index (MUNIX) in sarcopenic patients. Exp Gerontol 2013, 48:381-384.
20. Fanzani A., Zanola A., Faggi F., Papini N., Venerando B., Tettamanti G., et al. Implications for the mammalian sialidases in the physiopathology of skeletal muscle. Skelet Muscle 2012, 2:23.
21. Gabrielli M.G., Bondi A.M., Materazzi G., Menghi G. Differential location and structural specificities of sialic acid-beta-d-Gal sequences belonging to sialoderivatives of rabbit oviduct under hormonal treatment. Histol Histopathol 2004, 19:1175-1186.
22. Hoyte K., Kang C., Martin P.T. Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues. Mol Brain Res 2002, 109:146-160.
23. Huizing M., Krasnewich D.M. Hereditary inclusion body myopathy: a decade of progress. Biochim Biophys Acta 2009, 1792:881-887.
24. Jay C., Nemunaitis G., Nemunaitis J., Senzer N., Hinderlich S., Darvish D., et al. Preclinical Assessment of wt GNE Gene plasmid for management of Hereditary Inclusion Body Myopathy 2 (HIBM2). Gene Regul and Syst Biol 2008, 2:243-252.
25. Jay C.M., Levonyak N., Nemunaitis G., Maples P.B., Nemunaitis J. Hereditary Inclusion Body Myopathy (HIBM2). Gene Regul Syst Biol 2009, 3:181-190.
26. 1 subunit modulates voltage-gated sodium channel function. J Biol Chem 2004, 279:44303-44310.
27. Kung T.A., Cederna P.S., van der Meulen J.H., Urbanchek M.G., Kuzon W.M., Faulkner J.A. Motor unit changes seen with skeletal muscle sarcopenia in oldest old rats. J Gerontol A Biol Sci Med Sci 2013, 10.1093/gerona/glt135.
28. Lawniczak A., Kmiec Z. Age-related changes of skeletal muscles: physiology, pathology and regeneration. Postepy Hig Med Dosw 2012, 66:392-400.
29. McDearmon E.L., Combs A.C., Ervasti J.M. Core 1 glycans on α-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding. J Biol Chem 2003, 278:44868-44873.
30. Malicdan M.C., Noguchi S., Hayashi Y.K., Nonaka I., Nishino I. Prophylactic treatment with sialic acid metabolites preclude the development of a myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009, 15:690-695.
31. Malicdan M.C.V., Noguchi S., Nishino I. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther Adv Neurol Disord 2010, 3:127-135.
32. Malicdan M.C., Noguchi S., Tokutomi T., Goto Y., Nonaka I., Hayashi Y.K., et al. Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy. J Biol Chem 2012, 287:2689-2705.
33. Marini M., Bonaccini L., Thyrion G.D., Vichi D., Parretti E., Sgambati E. Distribution of sugar residues in human placentas from pregnancies complicated by hypertensive disorders. Acta Histochem 2011, 113:815-825.
34. Marini M., Sarchielli E., Toce M., Acocella A., Bertolai R., Ciulli C., et al. Expression and localization of VEGF receptors in human fetal skeletal tissues. Histol Histopathol 2012, 27:1579-1587.
35. Marini M., Ambrosini S., Sgambati E. Sialic acid expression in human skeletal muscle tissue during aging. 67th Congress of Italian Society of Anatomy and Histology. Brescia, 20-22 September 2013. It J Anat Embryol 2013, 118(Suppl.):133. [Abstract].
36. Mitchell W.K., Williams J., Atherton P., Larvin M., Lund J., Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 2012, 3:260. 10.3389/fphys.2012.00260.
37. Montero-Fernandez N., Serra-Rexach J.A. Role of exercise on sarcopenia in elderly. Eur J Phys Rehabil Med 2013, 49:131-143.
38. Müthing J., Maurer U., Weber-Schürholz S. Glycosphingolipids of skeletal muscle: II. Modulation of Ca2(+)-flux in triad membranes by gangliosides. Carbohydr Res 1998, 307:147-157.
39. Niethamer T.K., Yardeni T., Leoyklang P., Ciccone C., Astiz-Martinez A., Jacobs K., et al. Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy. Mol Genet Metab 2012, 107:748-755.
40. Nilsson J., Nilsson J., Larson G., Grahn A. Characterization of site-specific O-glycan structures within the mucin-like domain of α-dystroglycan from human skeletal muscle. Glycobiology 2010, 20:1160-1169.
41. Nilwik R., Snijders T., Leenders M., Groen B.B., van Kranenburg J., Verdijk L.B., et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 2013, 48:492-498.
42. Nishino I., Noguchi S. Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles. Brain Nerve 2012, 64:255-261.
43. Nishino I., Noguchi S. Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy). Rinsho Shinkeigaku 2012, 52:1210-1212.
44. O'Connell K., Doran P., Gannon J., Ohlendieck K. Lectin-based proteomic profiling of aged skeletal muscle: decreased pyruvate kinase isozyme M1 exhibits drastically increased levels of N-glycosylation. Eur J Cell Biol 2008, 87:793-805.
45. Olsen M., Zuber C., Roth J., Linnemann D., Bock E. The ability to re-express polysialylated NCAM in soleus muscle after denervation is reduced in aged rats compared to young adult rats. Int J Dev Neurosci 1995, 13:97-104.
46. Paccalet T., Coulombe Z., Tremblay J.P. Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as cellular marker of the disease. Plos One 2010, 5:e10055. 10.1371/journal.pone.0010055.
47. Rafuse V.F., Landmesser L.T. The pattern of avian intramuscular nerve branching is determined by the innervating motoneuron and its level of polysialic acid. J Neurosci 1996, 20:1056-1065.
48. Rønn L.C., Berezin V., Bock E. The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci 2000, 18:193-199.
49. Sakuma K., Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol 2012, 127362. 10.1155/2012/127362.
50. Saito F., Tomimitsu H., Arai K., Nakai S., Kanda T., Shimizu T., et al. A Japanese patient with distal myopathy with rimmed vacuoles: missense mutations in the epimerase domain of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene accompanied by hyposialylation of skeletal muscle glycoproteins. Neuromuscul Disord 2004, 14:158-161.
51. Schauer R. Sialic acids: fascinating sugar in higher animals and man. Zoology 2004, 107:49-64.
52. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 2009, 19:507-514.
53. Schiaffino S., Dyar K.A., Ciciliot S., Blaauw B., Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013, 280:4294-4314.
54. Schwetz T.A., Norring S.A., Ednie A.R., Bennett E.S. Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating. J Biol Chem 2011, 286:4123-4132.
55. Sharples A.P., Player D.J., Martin N.R., Mudera V., Stewart C.E., Lewis M.P. Modelling in vivo skeletal muscle ageing in vitro using three-dimensional bioengineered constructs. Aging Cell 2012, 11:986-995.
56. Shibuya N., Goldstein I.J., Broekaert W.F., Nsimba-Lubaki M., Peeters B., Peumans W.J. Fractionation of sialylated oligosaccharides, glycopeptides, and glycoproteins on immobilized elderberry (Sambucus nigra L.) barklectin. Arch Biochem Biophys 1987, 254:1-8.
57. Tajima Y., Uyama E., Go S., Sato C., Tao N., Kotani M., et al. Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins. Am J Pathol 2005, 166:1121-1130.
58. Valles-Ayoub Y., Esfandiarifard S., Sinai P., Carbajo R., Khokher Z., No D., et al. Serum neural cell adhesion molecule is hyposialylated in hereditary inclusion body myopathy. Genet Test Mol Biomarkers 2012, 16:313-317.
59. Varki A., Schauer Sialic acids. Essentials of glycobiology 2009, Cold Spring Harbor Laboratory Press, New York, [Chapter 14]. 2nd Edition. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
60. Voermans N.C., Guillardb M., Doedée R., Lammens M., Huizing M., Padberg G.W., et al. Clinical features, lectin staining, and a novel GNE frameshift mutation in HIBM. Clin Neuropathol 2010, 29:71-77.
61. Wall B.T., Dirks M.L., van Loon L.J. Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia. Ageing Res Rev 2013, 12:898-906.
62. Walston J.D. Sarcopenia in older adults. Curr Opin Rheumatol 2012, 24:623-627.
63. Wang W.C., Clark G.F., Smith D.F., Cummings R.D. Separation of oligosaccharides containing terminal alpha-linked galactose residues by affinity chromatography on Griffonia simplicifolia I bound to concanavalin A-sepharose. Anal Biochem 1988, 175:390-396.
64. Ziak M., Qu B., Zuo X., Zuber C., Kanamori A., Kitajima K., et al. Occurrence of poly(alpha2,8-deaminoneuraminic acid) in mammalian tissues: widespread and developmentally regulated but highly selective expression on glycoproteins. Proc Natl Acad Sci USA 1996, 93:2759-2763.